- 
            Purposelentiviral expression of c-Myc
 - 
              Depositing Lab
 - 
          Sequence Information
 
Ordering
| Item | Catalog # | Description | Quantity | Price (USD) | |
|---|---|---|---|---|---|
| Plasmid | 46970 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $89 | |
Backbone
- 
            Vector backbonePCDH-CMV-MCS-EF1-PURO
 - 
              Backbone manufacturerSystem Biosciences
 - Total vector size (bp) 7384
 - 
              Vector typeMammalian Expression, Lentiviral
 - 
                Selectable markersPuromycin
 
Growth in Bacteria
- 
            Bacterial Resistance(s)Ampicillin, 100 μg/mL
 - 
            Growth Temperature37°C
 - 
            Growth Strain(s)Stbl3
 - 
            Copy numberUnknown
 
Gene/Insert
- 
                Gene/Insert nameMYC
 - 
                  Alt namev-myc avian myelocytomatosis viral oncogene homolog
 - 
                  Alt namec-MYC
 - 
                  Alt nameMRTL
 - 
                    SpeciesH. sapiens (human)
 - 
                  Insert Size (bp)1323
 - 
                        Entrez GeneMYC (a.k.a. MRTL, MYCC, bHLHe39, c-Myc)
 - Promoter CMV
 
Cloning Information
- Cloning method Restriction Enzyme
 - 5′ cloning site EcoRI (not destroyed)
 - 3′ cloning site BamHI (not destroyed)
 - 5′ sequencing primer CMV-F (Common Sequencing Primers)
 
Resource Information
- 
            
            
            Addgene Notes
 - 
            Articles Citing this Plasmid
 
Terms and Licenses
- 
        Academic/Nonprofit Terms
 - 
      Industry Terms
- Not Available to Industry
 
 
Trademarks:
- Zeocin® is an InvivoGen trademark.
 
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
- 
              
For your Materials & Methods section:
pCDH-puro-cMyc was a gift from Jialiang Wang (Addgene plasmid # 46970 ; http://n2t.net/addgene:46970 ; RRID:Addgene_46970) - 
                
For your References section:
Inhibition of BET bromodomain targets genetically diverse glioblastoma. Cheng Z, Gong Y, Ma Y, Lu K, Lu X, Pierce LA, Thompson RC, Muller S, Knapp S, Wang J. Clin Cancer Res. 2013 Apr 1;19(7):1748-59. doi: 10.1158/1078-0432.CCR-12-3066. Epub 2013 Feb 12. 10.1158/1078-0432.CCR-12-3066 PubMed 23403638